UNSPSC 85581601: Revision of nonautologous tissue substitute in mouth and throat, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in mouth and throat, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CWY3KZ

UNSPSC 85581601 Revision of nonautologous tissue substitute in mouth and throat, percutaneous approach is a Commodity code, but the recent state and local opportunities tagged under it do not reflect tissue-substitute procurement or surgical revision procedures. Instead, the solicitations address occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical center-of-excellence carve-outs, and youth detention medical services—none of which align with the nominal scope of nonautologous tissue revision. The code shows no relevant recent activity for the work its title describes.

State and local procurement activity under this code is minimal and misfiled. The Washington State Department of Transportation (occupational medical surveillance with a pre-bid conference on August 31, 2026, responses due October 9, 2026), the City of Phoenix Retirement Office (disability medical evaluations, responses due October 16, 2026), the City of Long Beach (surgical benefit carve-out for Centers of Excellence, responses due October 7, 2026), Collier County (pharmacy benefit management, responses due April 9, 2026), County of Santa Clara Health System (temporary health professional staffing across multiple ancillary clinical categories, responses due October 7, 2026), and Harris County Juvenile Probation Department (specialty and emergency medical services for detained youth, RFI responses due September 25, 2026) have all posted opportunities under this code in the past two months, but none involve tissue substitutes or surgical revision procedures. The geographic spread spans Washington, Arizona, California, and Texas. The misfiling appears systematic across multiple jurisdictions and suggests the code assignment does not reflect actual procurement intent. Vendors in tissue-substitute manufacturing or surgical revision should not rely on this code for state and local opportunity identification.